Corcept Therapeutics
CORT
#3294
Rank
A$6.34 B
Marketcap
A$59.62
Share price
2.06%
Change (1 day)
-52.44%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of December 2025 : A$8.73 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is A$8.73 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2025-12-31A$9.11 M-18.24%
2024-12-31A$11.15 M4931.3%
2023-12-31A$0.22 M-86.8%
2022-12-31A$1.67 M131.5%
2021-12-31A$0.72 M-78.13%
2020-12-31A$3.31 M-32.89%
2019-12-31A$4.94 M
2018-12-31N/A
2016-12-31A$20.34 M-0.97%
2015-12-31A$20.54 M78.39%
2014-12-31A$11.51 M78.85%
2013-12-31A$6.43 M152.49%
2012-12-31A$2.55 M
2010-12-31N/A-100%
2009-12-31A$0 M-70.55%
2008-12-31A$0.02 M-31.63%
2007-12-31A$0.03 M-37.74%
2006-12-31A$0.05 M-27.81%
2005-12-31A$0.07 M
2003-12-31A$0.7 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$68.54 B 784,786.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$50.58 B 579,169.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$91.46 B 1,047,239.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$60.78 B 695,871.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$70.55 B 807,808.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$67.40 B 771,784.72%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$0.17 B 1,863.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.43 B 4,923.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.86 B 9,820.76%๐Ÿ‡บ๐Ÿ‡ธ USA